Participation of lnterleukin-5, Interleukin-8 and Leukotriene B4 in Eosinophil Accumulation in Two Different Experimental Models

Memorias do Instituto Oswaldo Cruz

Volumn 92 SUPPL. 2, Issue , 1997, Pages 205-210

  Oliveira, Sandra H P ^a   Faccioli, Lúcia H ^a   Ferreira, Sérgio H ^a   Cunha, Fernando Q ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Eosinophil migration; Interleukin 5; Interleukin 8; Leukotrine B4; Saline; Sephadex

Indexed keywords

INTERLEUKIN 5; INTERLEUKIN 8; LEUKOTRIENE B4; SODIUM CHLORIDE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CELL MOTION; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; EOSINOPHIL; MACROPHAGE; MAST CELL; PERITONEAL CAVITY; PHYSIOLOGY; RAT;

ANALYSIS OF VARIANCE; ANIMALS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; EOSINOPHILS; INTERLEUKIN-5; INTERLEUKIN-8; LEUKOTRIENE B4; MACROPHAGES; MAST CELLS; PERITONEAL CAVITY; RATS; SODIUM CHLORIDE;

EID: 0031317763     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761997000800028     Document Type: Article

References (34)

1. Auriault C, Capron K, Cesarl IM, Capron A 1983. Enhancement of eosinophil effector function by soluble factors released by S. mansoni: role of protease. J Immunol 131: 464-470.
2. Barnes PJ, Chung KF, Page CP 1988. Inflammatory mediators in asthma. Pharmacol Rev 40: 49-84.
3. Bascom R, Pipkorn U, Proud D, Dunnette S, Gleich GJ, Lichtenstein LM, Naclerio RM 1989. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol 84: 338-346.
4. Berman JS, Weller PF 1992. Airway eosinophils and lymphocytes in asthma. Am Rev Respir Dis 145: 1246-1248.
5. Capron M 1992. Dual function of eosinophils in pathogenesis and protective immunity against parasites. Mem Inst Oswalde Cruz 87 (Suppl V): 83-89.
6. Collins PD, Weg VB, Faccioli LH, Watson ML, Moqbel R, Williams TJ 1993. Eosinophil accumulation induced by human interleukin-8 in the guinea pig in vivo. Immunology 79: 312-318.
7. Cook NS 1988. The pharmacology of potassium channels and their therapeutic potential. TIPS 91: 21-28.
8. Cook RM, Musgrove NRJ, Ashworth RF 1987. Activity of rat peritoneal eosinophils following induction by different methods. Int Archs Allergy Appl Immunol 83: 423-427.
9. 4. Int Arch Allergy Immunol 88: 191-193.
10. Davies WB, Fells GA, Sun X-H, Gadek JE, Venet A, Crystal RG 1984. Eosinophil mediated injury to lung parenchyma cells and interstitial matrix. A possible role for eosinophil in chronic inflammatory disorders of the lower respiratory tract. J Clin Invest 74: 269-278.
11. 111 In-eosinophils induced by inflammatory mediators in vivo. Immunology 73: 222-227.
12. Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutte PM 1988. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 81: 776-781.
13. Grleich GJ 1990. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 85: 422-435.
14. Hakansson L, Westerlund D, Venge P 1987. New method for the measurement of eosinophil migration. J Leukocyte Biol 42: 689-696.
15. Holgate ST 1991. The mast cell and its function in allergic disease. Clin Exp Allergy 21: 11-16.
16. Janiszewski J, Huizinga JD, Blennerhassett MG 1992. Mast cell ionic channels: significance for stimulus - secretion coupling. Can J Physiol Pharmacol 70: 1-7.
17. Jose PJ, Griffiths-Johnson DA, Collins PD, Wash DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Willians TJ 1994. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179: 881-887.
18. Kameyoshi Y, Dorschner A, Malet AI, Christophers E, Schroder J-M 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176: 587-592.
19. Kay AB 1985. Eosinophils as effector cells in immunity and hypersensitivity disorders. Clin Exp Immunol 62: 1-12.
20. Lee TH, Lane SJ 1992. The role of macrophages in the mechanisms of airway inflammation in asthma. Am Rev Respir Dis 145: S27-S30.
21. Leiferman KM, Ackerman SJ, Haugen HA, Venencie PY, Gleich GJ 1985. Dermal deposition of eosinophil granule major basic protein in atopic dermatitis. N Engl J Med 313: 282-285.
22. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA 1988. Recombinant human interleukin 5 is selective activator of human eosinophil function. J Exp Med 167: 219-224.
23. Maghni K, Blanchette F, Sirois P 1993. Induction of lung eosinophilia and neutrophilia in guinea-pig following injection of sephadex beads. Inflammation 17: 536-550.
24. Meacock SCR, Brandon DR, Smith W 1991. Interleukin2 receptors on rat eosinophils in adjuvant arthritis. Immunology 74: 169-171.
25. O'Donnell MC, Ackerman SJ, Gleich GJ, Thomas LL 1983. Activation of mast cell and basophil histamine release by eosinophil granule major basic protein. J Exp Med 157: 1981-1991.
26. Ogawa H, Kunkel SL, Fantone JC, Ward PA 1981. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release. Am J Pathol 105: 149-155.
27. 2 and histamine activate human eosinophils. J Immunol 148: 3536-3542.
28. Rand TH, Silberstein DS, Kornfeld H, Weller PF 1991. Human eosinophils express functional interleukin 2 receptor. J Clin Invest 88: 825-832.
29. Resnick MB, Weller PF 1993 Mechanism of eosinophil recruitment. Am J Resp Cell Mol Biol 8: 349-355.
30. Schriber RA, Zucker-Franklin D 1974. A method for the induction of blood eosinophils with simple protein antigens. Cell Immunol 14: 470-474.
31. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB 1992. Interleukin 5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophil subjects. Blood 79: 2952-2959.
32. Spicer BA, Baker RC, Halt PA, Laycock SM, Smith H 1990. The effecs of drugs on Sephadex-induced eosinophilia and lung hyper-responsiveness. Br J Pharmacol 101: 821-828.
33. Sun X-H, Davis WB, Fukuda Y, Ferrans VJ, Crystal RG 1985. Experimental polymyxin B-induced interstitial lung disease characterised by an accumulation of cytotoxic eosinophils in the alveolar structures. Am Rev Resp Dis 131: 103-108.
34. Walls RS 1977. Eosinophil response to alum adjuvant: involvement of T cells in non-antigen-dependent mechanisms. Proc Soc exp Biol Med 156: 431-435.